GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Navana Pharmaceuticals PLC (DHA:NAVANAPHAR) » Definitions » Gross-Profit-to-Asset %

Navana Pharmaceuticals (DHA:NAVANAPHAR) Gross-Profit-to-Asset % : 0.00% (As of . 20)


View and export this data going back to 2022. Start your Free Trial

What is Navana Pharmaceuticals Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Navana Pharmaceuticals's annualized Gross Profit for the quarter that ended in . 20 was BDT Mil. Navana Pharmaceuticals's average Total Assets over the quarter that ended in . 20 was BDT 0 Mil. Therefore, Navana Pharmaceuticals's annualized Gross-Profit-to-Asset % for the quarter that ended in . 20 was Not Available.

Navana Pharmaceuticals Gross-Profit-to-Asset % Historical Data

The historical data trend for Navana Pharmaceuticals's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Navana Pharmaceuticals Gross-Profit-to-Asset % Chart

Navana Pharmaceuticals Annual Data
Trend
Gross-Profit-to-Asset %

Navana Pharmaceuticals Semi-Annual Data
Gross-Profit-to-Asset %

Competitive Comparison of Navana Pharmaceuticals's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Navana Pharmaceuticals's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Navana Pharmaceuticals's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Navana Pharmaceuticals's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Navana Pharmaceuticals's Gross-Profit-to-Asset % falls into.


;
;

Navana Pharmaceuticals Gross-Profit-to-Asset % Calculation

Navana Pharmaceuticals's annualized Gross-Profit-to-Asset % for the fiscal year that ended in . 20 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: . 20 )/( (Total Assets (A: . 20 )+Total Assets (A: . 20 ))/ count )
=/( (+)/ )
=/
= %

Navana Pharmaceuticals's annualized Gross-Profit-to-Asset % for the quarter that ended in . 20 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: . 20 )/( (Total Assets (Q: . 20 )+Total Assets (Q: . 20 ))/ count )
=/( (+)/ )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is one times the annual (. 20) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Navana Pharmaceuticals Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Navana Pharmaceuticals's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Navana Pharmaceuticals Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Navana Pharmaceuticals PLC (DHA:NAVANAPHAR) » Definitions » Gross-Profit-to-Asset %
Comparable Companies
Traded in Other Exchanges
N/A
Address
Road 4, House 99, Block B, Banani, Dhaka, BGD, 1213
Website
https://www.navanapharma.com
Navana Pharmaceuticals PLC operates its business under two divisions namely Veterinary Division and Human Health Division. Veterinary Division manufactures and markets high-quality veterinary medicine and feed supplements for different segments including poultry, dairy and aqua products. Human Health Division operates its manufacturing facilities in strict compliance with WHO cGMP guidelines for the production of tablets, capsules, oral liquids, ampoules, dry powder vials, powder for suspension, eye drops, creams and ointments.

Navana Pharmaceuticals Headlines

No Headlines